NEW YORK, Feb 9 - Packard BioScience said Friday it had filed a statement with the US Securities and Exchange Commission for a follow-on offering of 10 million shares.

Packard of Meriden, Conn., said it would issue three million of the shares, while shareholders, including CEO Emery Olcott and Senior Vice President Richard McKernan, intend to sell an additional seven million shares.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The UK's Human Fertility and Embryology Authority calls for consumer genetic testing companies to warn customers that testing could uncover family secrets, according to the Guardian.

The New York Times reports that United Nations delegates have been discussing how to govern the genetic resources of the deep sea.

Researchers have transplanted edited cells into mice that appear to combat cocaine addiction, New Scientist reports.

In PNAS this week: analysis of proteolytic enzymes secreted by circulating tumor cells, phylogenetic study of Fv1 evolution, and more.